These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36924644)

  • 1. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada.
    Wong JK; Lim HJ; Tam VC; Burak KW; Dawson LA; Chaudhury P; Abraham RJ; Meyers BM; Sapisochin G; Valenti D; Samimi S; Ramjeesingh R; Mujoomdar A; Martins I; Dixon E; Segedi M; Liu DM
    Cancer Treat Rev; 2023 Apr; 115():102526. PubMed ID: 36924644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy.
    Patel M; Pillai A
    Surg Oncol Clin N Am; 2024 Jan; 33(1):159-172. PubMed ID: 37945141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review.
    Alnammi M; Wortman J; Therrien J; Afnan J
    Abdom Radiol (NY); 2022 Jul; 47(7):2299-2313. PubMed ID: 35524803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress.
    Brown ZJ; Hewitt DB; Pawlik TM
    Expert Opin Investig Drugs; 2022 Apr; 31(4):379-391. PubMed ID: 34788184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
    Memon K; Kulik L; Lewandowski RJ; Gupta R; Ryu RK; Miller FH; Vouche M; Atassi R; Ganger D; Mulcahy MF; Salem R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1189-1197.e2. PubMed ID: 23474327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advances for patients with intermediate hepatocellular carcinoma.
    Sun JY; Yin T; Zhang XY; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12116-12121. PubMed ID: 30648254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma.
    Dhir M; Melin AA; Douaiher J; Lin C; Zhen WK; Hussain SM; Geschwind JF; Doyle MB; Abou-Alfa GK; Are C
    Ann Surg; 2016 Jun; 263(6):1112-25. PubMed ID: 26813914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Kis B; El-Haddad G; Sheth RA; Parikh NS; Ganguli S; Shyn PB; Choi J; Brown KT
    Cancer Control; 2017; 24(3):1073274817729244. PubMed ID: 28975829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
    Llovet JM; De Baere T; Kulik L; Haber PK; Greten TF; Meyer T; Lencioni R
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):293-313. PubMed ID: 33510460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Local and Systemic Therapies for Hepatocellular Cancer.
    Mokdad AA; Singal AG; Yopp AC
    Curr Oncol Rep; 2016 Feb; 18(2):9. PubMed ID: 26769114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter arterial chemoembolization based on hepatic hemodynamics for hepatocellular carcinoma.
    Murata S; Mine T; Ueda T; Nakazawa K; Onozawa S; Yasui D; Kumita S
    ScientificWorldJournal; 2013; 2013():479805. PubMed ID: 23606815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.
    Cheng AL; Amarapurkar D; Chao Y; Chen PJ; Geschwind JF; Goh KL; Han KH; Kudo M; Lee HC; Lee RC; Lesmana LA; Lim HY; Paik SW; Poon RT; Tan CK; Tanwandee T; Teng G; Park JW
    Liver Int; 2014 Feb; 34(2):174-83. PubMed ID: 24251922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional oncology for hepatocellular carcinoma.
    Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.